486 related articles for article (PubMed ID: 31963413)
1. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges.
Kunimasa K; Goto T
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963413
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
Leonetti A; Wever B; Mazzaschi G; Assaraf YG; Rolfo C; Quaini F; Tiseo M; Giovannetti E
Drug Resist Updat; 2019 Sep; 46():100644. PubMed ID: 31585395
[TBL] [Abstract][Full Text] [Related]
4. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
Vesely MD; Schreiber RD
Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
[TBL] [Abstract][Full Text] [Related]
5. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.
Yang J; Chen J; Wei J; Liu X; Cho WC
Expert Opin Biol Ther; 2016 Oct; 16(10):1209-23. PubMed ID: 27426430
[TBL] [Abstract][Full Text] [Related]
7. PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future Directions.
Xia L; Liu Y; Wang Y
Oncologist; 2019 Feb; 24(Suppl 1):S31-S41. PubMed ID: 30819829
[TBL] [Abstract][Full Text] [Related]
8. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
[TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).
Yoneda K; Imanishi N; Ichiki Y; Tanaka F
J UOEH; 2018; 40(2):173-189. PubMed ID: 29925736
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for non-small-cell lung cancer.
Thomas A; Jakopovic M
Expert Opin Biol Ther; 2014 Aug; 14(8):1061-4. PubMed ID: 24878420
[TBL] [Abstract][Full Text] [Related]
11. Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
Qiao M; Jiang T; Ren S; Zhou C
Clin Lung Cancer; 2018 Jan; 19(1):1-11. PubMed ID: 28716463
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in non-small-cell lung cancer: a bridge between research and clinical practice.
Passiglia F; Commendatore O; Vitali M; Conca R
Future Oncol; 2018 Jun; 14(13s):41-60. PubMed ID: 29989452
[TBL] [Abstract][Full Text] [Related]
13. Emerging biomarkers for immune checkpoint inhibition in lung cancer.
Cyriac G; Gandhi L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):269-277. PubMed ID: 29782924
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunoediting: from immunosurveillance to tumor escape.
Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD
Nat Immunol; 2002 Nov; 3(11):991-8. PubMed ID: 12407406
[TBL] [Abstract][Full Text] [Related]
15. The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly.
Sgambato A; Casaluce F; Gridelli C
Expert Opin Biol Ther; 2017 May; 17(5):565-571. PubMed ID: 28276698
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions.
Soo RA; Lim SM; Syn NL; Teng R; Soong R; Mok TSK; Cho BC
Lung Cancer; 2018 Jan; 115():12-20. PubMed ID: 29290252
[TBL] [Abstract][Full Text] [Related]
17. Natural innate and adaptive immunity to cancer.
Vesely MD; Kershaw MH; Schreiber RD; Smyth MJ
Annu Rev Immunol; 2011; 29():235-71. PubMed ID: 21219185
[TBL] [Abstract][Full Text] [Related]
18. Combining immunotherapies to treat non-small cell lung cancer.
Spagnuolo A; Gridelli C
Expert Rev Respir Med; 2019 Jul; 13(7):621-634. PubMed ID: 31116072
[No Abstract] [Full Text] [Related]
19. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
20. Patrolling monocytes control tumor metastasis to the lung.
Hanna RN; Cekic C; Sag D; Tacke R; Thomas GD; Nowyhed H; Herrley E; Rasquinha N; McArdle S; Wu R; Peluso E; Metzger D; Ichinose H; Shaked I; Chodaczek G; Biswas SK; Hedrick CC
Science; 2015 Nov; 350(6263):985-90. PubMed ID: 26494174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
